04/20/20
RUTGERS, UNIVERSITY HOSPITAL LEAD WAY IN TREATING COVID-19 WITH CONVALESCENT PLASMA FROM RECOVERED PATIENTS
Researchers, doctors call for more blood donations from former patients to help treat critically ill
Rutgers physicians and University Hospital are leading the way in using blood plasma from patients who recovered from COVID-19 to treat new patients who are severely ill with COVID-19 infections. The clinicians and hospital are calling for more blood donations from those who have survived the deadly infection.
Although COVID-19 infections and fatalities continue to increase in New Jersey and across the United States, more than 50,000 people have recovered from the novel virus. Their blood plasma
contains antibodies that may help critically ill patients fight, and perhaps conquer, the virus.
Last Friday, Rutgers practitioners at University Hospital received the first FDA approval for this treatment in New Jersey, and have thus far treated 17 patients with convalescent plasma. FDA
approval is pending for the use of this treatment for additional patients.
The effectiveness of this treatment is not yet known, though similar treatment has been studied for Ebola and the MERS virus. Practitioners and researchers will monitor and investigate the progress of COVID-19 patients who receive this treatment.
“The use of convalescent plasma – blood plasma from individuals who have recovered from COVID-19 – presents real hope for saving lives,” said Marc Klapholz, Chair of the Department of Medicine at Rutgers New Jersey Medical School and University Hospital, and the Principal Investigator for the use of Convalescent COVID-19 plasma.
“In our battle against the COVID-19 virus, we are excited to be trialing this potential life-saving therapy in partnership with Rutgers New Jersey Medical School. This treatment plan has been
used for more than 100 years to address disease outbreaks for other conditions, and we’re optimistic that it will save lives,” said Shereef Elnahal, President and CEO of University Hospital.
People interested in donating plasma must have had a confirmed positive test for COVID-19 from a lab or health facility and be eligible to donate blood. They can reach the Rutgers and
University Hospital COVID-19 Treatment Group at 973-972-5474 or via email at covidplasma@uhnj.org.
UNIVERSITY HOSPITAL TRAUMA RECOVERY PROGRAMS RECOGNIZED BY STATE OF NEW JERSEY; SIMILAR WORK, IN PARTNERSHIP WITH THE CITY OF NEWARK, HONORED BY OBAMA FOUNDATION
The Trauma Recovery Center (TRC) and Hospital-Based Violence Intervention Program (HVIP) at University Hospital (UH) recently received the Crime Victims’ Rights Award by the State of New Jersey. Additionally, the work of both programs, in partnership with the City of Newark, were honored as part of the City’s recognition as a My Brother’s Keeper (MBK) …
UNIVERSITY HOSPITAL ANNOUNCES 50% REDUCTION IN LENGTH OF STAY FOR NEONATAL ABSTINENCE SYNDROME BABIES AS A RESULT OF ITS HIGHLY SUCCESSFUL N.A.S.T.O.P. PROGRAM
University Hospital announced today that its Neonatal Abstinence Syndrome Treatment & Observation Protocols (N.A.S.T.O.P.) program has successfully reduced the average length of stay duration for babies suffering from neonatal abstinence syndrome by more than 50%, from more than 42 to days to fewer than 20 days. The program has also decreased the neonatal abstinence treatment …
UNIVERSITY HOSPITAL AND FIRST LADY TAMMY MURPHY HOST SURGEON GENERAL FOR MATERNAL HEALTH LISTENING SESSION
On Thursday, January 9th , University Hospital and First Lady Tammy Murphy hosted Surgeon General, VADM Jerome M. Adams, M.D., M.P.H., for a Maternal Mortality & Morbidity Listening Session. Dr. Adams moderated a panel discussion with healthcare providers, State and local leaders, and other stakeholders on the efforts underway in New Jersey to address these …